271 related articles for article (PubMed ID: 34387765)
21. Pressurized Intraperitoneal Aerosol Chemotherapy (Oxaliplatin) for Unresectable Colorectal Peritoneal Metastases: A Multicenter, Single-Arm, Phase II Trial (CRC-PIPAC).
Rovers KP; Wassenaar ECE; Lurvink RJ; Creemers GM; Burger JWA; Los M; Huysentruyt CJR; van Lijnschoten G; Nederend J; Lahaye MJ; Deenen MJ; Wiezer MJ; Nienhuijs SW; Boerma D; de Hingh IHJT
Ann Surg Oncol; 2021 Sep; 28(9):5311-5326. PubMed ID: 33544279
[TBL] [Abstract][Full Text] [Related]
22. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) for peritoneal malignancy: initial experience of the first program in the Baltic countries.
Račkauskas R; Baušys A; Lukšta M; Jurgaitis J; Paškonis M; Strupas K
World J Surg Oncol; 2021 Aug; 19(1):236. PubMed ID: 34376191
[TBL] [Abstract][Full Text] [Related]
23. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) of peritoneal metastasis from gastric cancer: a descriptive cohort study.
Ellebæk SB; Graversen M; Detlefsen S; Lundell L; Fristrup CW; Pfeiffer P; Mortensen MB
Clin Exp Metastasis; 2020 Apr; 37(2):325-332. PubMed ID: 32002724
[TBL] [Abstract][Full Text] [Related]
24. Treatment of peritoneal carcinomatosis with Pressurized IntraPeritoneal Aerosol Chemotherapy - PIPAC-OPC2.
Graversen M; Detlefsen S; Asmussen J; Mahdi B; Fristrup C; Pfeiffer P; Mortensen MB
Pleura Peritoneum; 2018 Jun; 3(2):20180108. PubMed ID: 30911656
[TBL] [Abstract][Full Text] [Related]
25. Severe peritoneal sclerosis after repeated pressurized intraperitoneal aerosol chemotherapy with oxaliplatin (PIPAC OX): report of two cases and literature survey.
Graversen M; Detlefsen S; Pfeiffer P; Lundell L; Mortensen MB
Clin Exp Metastasis; 2018 Mar; 35(3):103-108. PubMed ID: 29705882
[TBL] [Abstract][Full Text] [Related]
26. Systemic chemotherapy and pressurized intraperitoneal aerosol chemotherapy (PIPAC): A bidirectional approach for gastric cancer peritoneal metastasis.
Di Giorgio A; Schena CA; El Halabieh MA; Abatini C; Vita E; Strippoli A; Inzani F; Rodolfino E; Romanò B; Pacelli F; Rotolo S
Surg Oncol; 2020 Sep; 34():270-275. PubMed ID: 32891341
[TBL] [Abstract][Full Text] [Related]
27. A phase I, single-arm, open-label, dose escalation study of intraperitoneal cisplatin and doxorubicin in patients with recurrent ovarian cancer and peritoneal carcinomatosis.
Tempfer CB; Giger-Pabst U; Seebacher V; Petersen M; Dogan A; Rezniczek GA
Gynecol Oncol; 2018 Jul; 150(1):23-30. PubMed ID: 29743140
[TBL] [Abstract][Full Text] [Related]
28. Feasibility and Safety of Oxaliplatin-Based Pressurized Intraperitoneal Aerosol Chemotherapy With or Without Intraoperative Intravenous 5-Fluorouracil and Leucovorin for Colorectal Peritoneal Metastases: A Multicenter Comparative Cohort Study.
Taibi A; Sgarbura O; Hübner M; Bardet SM; Alyami M; Bakrin N; Durand Fontanier S; Eveno C; Gagniere J; Pache B; Pocard M; Quenet F; Teixeira Farinha H; Thibaudeau E; Dumont F; Glehen O
Ann Surg Oncol; 2022 Aug; 29(8):5243-5251. PubMed ID: 35318519
[TBL] [Abstract][Full Text] [Related]
29. Chemosensitivity of various peritoneal cancer cell lines to HIPEC and PIPAC: comparison of an experimental duplex drug to standard drug regimens in vitro.
Weinreich J; Struller F; Sautkin I; Giuashvili S; Reymond M; Königsrainer A; Schott TC
Invest New Drugs; 2019 Jun; 37(3):415-423. PubMed ID: 30019100
[TBL] [Abstract][Full Text] [Related]
30. Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) with Oxaliplatin, Cisplatin, and Doxorubicin in Patients with Peritoneal Carcinomatosis: An Open-Label, Single-Arm, Phase II Clinical Trial.
De Simone M; Vaira M; Argenziano M; Berchialla P; Pisacane A; Cinquegrana A; Cavalli R; Borsano A; Robella M
Biomedicines; 2020 Apr; 8(5):. PubMed ID: 32365877
[TBL] [Abstract][Full Text] [Related]
31. Clinical Outcome for Patients Managed with Low-Dose Cisplatin and Doxorubicin Delivered as Pressurized Intraperitoneal Aerosol Chemotherapy for Unresectable Peritoneal Metastases of Gastric Cancer.
Sindayigaya R; Dogan C; Demtröder CR; Fischer B; Karam E; Buggisch JR; Tempfer CB; Lecomte T; Ouaissi M; Giger-Pabst U
Ann Surg Oncol; 2022 Jan; 29(1):112-123. PubMed ID: 34611790
[TBL] [Abstract][Full Text] [Related]
32. Quality of life of patients with end-stage peritoneal metastasis treated with Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC).
Odendahl K; Solass W; Demtröder C; Giger-Pabst U; Zieren J; Tempfer C; Reymond MA
Eur J Surg Oncol; 2015 Oct; 41(10):1379-85. PubMed ID: 26138283
[TBL] [Abstract][Full Text] [Related]
33. Multicentric initial experience with the use of the pressurized intraperitoneal aerosol chemotherapy (PIPAC) in the management of unresectable peritoneal carcinomatosis.
Alyami M; Gagniere J; Sgarbura O; Cabelguenne D; Villeneuve L; Pezet D; Quenet F; Glehen O; Bakrin N; Passot G
Eur J Surg Oncol; 2017 Nov; 43(11):2178-2183. PubMed ID: 28964609
[TBL] [Abstract][Full Text] [Related]
34. Letter to the Editor of Annals of Surgical Oncology Concerning "Safety and Efficacy of Oxaliplatin Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Colorectal and Appendiceal Cancer with Peritoneal Metastases: Results of a Multicenter Phase I Trial in the USA".
Chiu CC
Ann Surg Oncol; 2024 Apr; 31(4):2405-2407. PubMed ID: 37971615
[No Abstract] [Full Text] [Related]
35. No Renal Toxicity After Repeated Treatment with Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) in Patients with Unresectable Peritoneal Metastasis.
Larbre V; Alyami M; Mercier F; Vantard N; Bonnefoy I; Opsomer MA; Villeneuve L; Bakrin N; Rioufol C; Glehen O; Kepenekian V
Anticancer Res; 2018 Dec; 38(12):6869-6875. PubMed ID: 30504403
[TBL] [Abstract][Full Text] [Related]
36. Pressurized intraperitoneal chemotherapy (PIPAC) in women with gynecologic malignancies: a review.
Tempfer CB; Solass W; Reymond MA
Wien Med Wochenschr; 2014 Dec; 164(23-24):519-28. PubMed ID: 25249025
[TBL] [Abstract][Full Text] [Related]
37. Severe hypersensitivity reactions to platinum compounds post-pressurized intraperitoneal aerosol chemotherapy (PIPAC): first literature report.
Siebert M; Alyami M; Mercier F; Gallice C; Villeneuve L; Bérard F; Glehen O; Bakrin N; Kepenekian V
Cancer Chemother Pharmacol; 2019 Mar; 83(3):425-430. PubMed ID: 30511218
[TBL] [Abstract][Full Text] [Related]
38. Safety of intraperitoneal paclitaxel combined with conventional chemotherapy for colorectal cancer with peritoneal carcinomatosis: a phase I trial.
Murono K; Nagata H; Ishimaru K; Emoto S; Kaneko M; Hiyoshi M; Sasaki K; Otani K; Shuno Y; Nishikawa T; Tanaka T; Hata K; Kawai K; Nozawa H; Muro K; Ishihara S
Cancer Chemother Pharmacol; 2019 Jan; 83(1):145-150. PubMed ID: 30386886
[TBL] [Abstract][Full Text] [Related]
39. Pressurized intraperitoneal aerosol chemotherapy with cisplatin and doxorubicin or oxaliplatin for peritoneal metastasis from pancreatic adenocarcinoma and cholangiocarcinoma.
Di Giorgio A; Sgarbura O; Rotolo S; Schena CA; Bagalà C; Inzani F; Russo A; Chiantera V; Pacelli F
Ther Adv Med Oncol; 2020; 12():1758835920940887. PubMed ID: 32782488
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
